SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...

Currax’s Derrick Gastineau discusses the drugmaker’s recently-launched Real Patients, Real Results campaign and its position in the weight loss market.

Burson reported a slight acceleration in like-for-like revenue decline in Q2, although there was positive news on new ...

Maternal health advocates say they’re working together to bring national attention to the potential funding threat to ERASE MM. Griffen, the executive director of the Maternal Mental Health Leadership ...

The new law imposes additional paperwork requirements on Obamacare enrollees, slashes the time they have each year to sign up and cuts funding for navigators who help them shop for plans.

AbbVie’s Skyrizi tallied the most TV impressions among pharma brands in July, rising from second in June. The psoriasis treatment achieved a share of voice (SOV) of 4.61% with 2.5 billion impressions.

Veterans hospitals are struggling to replace hundreds of doctors and nurses who have left the healthcare system this year.

Veterans hospitals are struggling to replace hundreds of doctors and nurses who have left the healthcare system this year. Get to know each of these companies by learning about their culture, ...

Propel Health Communications, a 2025 MM+M Agency 100 honoree, hired Christopher Thorn as SVP, creative director and Lauren ...

ViiV Healthcare’s Dr. Alftan Dyson shares looming gaps in HIV education and awareness amongst Black communities, and how marketers can address this.

NIH documents viewed by KFF Health News show a pronounced decline in patients at the 200-bed hospital from February through April.

Novo Nordisk’s head of U.S. marketing, Ulrich Otte, is no longer in the role and is exploring other internal opportunities at the company outside of the U.S.